Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Monty Allen Insider Profile
4 Followers
Monty Allen, Director at Iradimed, holds 18.05K shares in Iradimed (Ticker: IRMD), holds 15.00K shares in Lightpath Technologies (Ticker: LPTH). Most recently, Monty Allen Sold ― shares of Iradimed on Jun 04, 2024 for an estimated value of 84.42K.
Profitable Transactions
9 out of 16 Profitable Transactions
Average Return
-3.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Monty Allen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Monty Allen
Monty Allen's Trading History
Iradimed
Jun 04, 2024
Director
Informative Sell
84.42K
$1.03M
Lightpath Technologies
―
CFO & Secretary
―
$24.00K
List of latest transactions for each holding click on a transaction to see Monty Allen's performance on stock
You May Also Like
Monty Allen insider profile FAQ
What is the percentage of profitable transactions made by Monty Allen?
The percentage of profitable transactions made by Monty Allen is 56%.
What is the average return per transaction made by Monty Allen?
The average return per transaction made by Monty Allen is -3.90%.
What stocks does Monty Allen hold?
Monty Allen holds: IRMD, LPTH stocks.
What was Monty Allen’s latest transaction?
Monty Allen latest transaction was an Informative Sell of $84.42K.
What was Monty Allen's most profitable transaction?
Monty Allen’s most profitable transaction was an Informative Sell of IRMD stock on June 14, 2016. The return on the trade was 58.10%.
What is Monty Allen's role in Iradimed?
Monty Allen's role in Iradimed is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.